Drugs / 3D-cultured human placental mesenchymal stem cell-derived extracellular vesicles
3D-cultured human placental mesenchymal stem cell-derived extracellular vesicles
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07515066 | May 2026 → Apr 2028 expected | idiopathic pulmonary fibrosis | Huan Ye | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 3D-cultured human placental mesenchymal stem cell-derived extracellular vesicles | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07515066 ↗ |
| Modality | Other / unclassified | “3D-cultured human placental mesenchymal stem cell-derived extracellular vesicles” NCT07515066 ↗ |
| Route | Inhaled | “administered via nebulization inhalation” NCT07515066 ↗ |